Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Australian and New Zealand Journal of Public Health|June 8, 2012
Hospital-activity data inaccurate for determining spread-of-disease at diagnosis for non-small cell lung cancerBridie Thompson, Melanie Watson, Rayleen Bowman, et al.Cancer Journal (Sudbury, Mass.)|June 22, 2002
Molecular pathogenesis of lung cancer and potential translational applicationsJohn D Minna, Kwun Fong, Sabine Zöchbauer-Müller, et al.The Cochrane Database of Systematic Reviews|October 10, 2008
Platinum versus non-platinum chemotherapy regimens for small cell lung cancerIsuru U Amarasena, Julia A E Walters, Richard Wood-Baker, et al.Respirology (Carlton, Vic.)|January 14, 2019
Somatic mutations and immune checkpoint biomarkersBrielle A Parris, Eloise Shaw, Brendan Pang, et al.Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|February 25, 2025
Lung Cancer Screening Participation Among Indigenous Peoples Worldwide: A Systematic Review of Challenges and OpportunitiesSewunet Admasu Belachew, Habtamu Mellie Bizuayehu, Abbey Diaz, et al.The Journal of Allergy and Clinical Immunology|May 8, 2004
Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthmaMary-Anne Kedda, Jing Shi, David Duffy, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort studyEmily Stone, Nicole Rankin, Stephen Kerr, et al.Respirology (Carlton, Vic.)|April 12, 2018
Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi processEmily Stone, Nicole Rankin, Jane Phillips, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2018
Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in AustraliaStephen Wade, Marianne Weber, Michael Caruana, et al.Lung Cancer (Amsterdam, Netherlands)|September 7, 2010
Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?Prunella Blinman, Sue-Anne McLachlan, Anna K Nowak, et al.Pageof 3